Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Matthew Bang"'
Autor:
Kevin S Tang, MD MMS, Jeffrey E Jones, BS, Matthew Bang, BS, Wenjun Fan, MD, Nathan D Wong, PhD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100553- (2023)
Therapeutic Area: Diabetes Background: Hypertension (HTN) and diabetes mellitus (DM) are both leading contributors to the development of cardiovascular disease (CVD). Furthermore, HTN subtypes may impact CVD outcomes to varying degrees. Data are limi
Externí odkaz:
https://doaj.org/article/3cecdf3539db4032bcfe3426d543c800
Publikováno v:
American Journal of Preventive Cardiology, Vol 3, Iss , Pp 100047- (2020)
Externí odkaz:
https://doaj.org/article/fcc7e7c925d245488fff0fa005cb1fe0
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 14, p 3090 (2021)
Heterozygous familial hypercholesterolemia (HeFH) creates elevated low-density lipoprotein cholesterol (LDL-C), causing premature atherosclerotic cardiovascular disease (ASCVD). Guidelines recommend cascade screening relatives and starting statin the
Externí odkaz:
https://doaj.org/article/e1a595d47f6c45e6b3e89a2f6918ad99
Publikováno v:
Journal of clinical medicine, vol 10, iss 14
Journal of Clinical Medicine
Volume 10
Issue 14
Journal of Clinical Medicine, Vol 10, Iss 3090, p 3090 (2021)
Journal of Clinical Medicine
Volume 10
Issue 14
Journal of Clinical Medicine, Vol 10, Iss 3090, p 3090 (2021)
Heterozygous familial hypercholesterolemia (HeFH) creates elevated low-density lipoprotein cholesterol (LDL-C), causing premature atherosclerotic cardiovascular disease (ASCVD). Guidelines recommend cascade screening relatives and starting statin the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3c5e1d143203fb925130a863819e53
https://escholarship.org/uc/item/10m9971s
https://escholarship.org/uc/item/10m9971s
Publikováno v:
The American Journal of Cardiology.
Heterozygous familial hypercholesterolemia (HeFH) results in significant elevations in LDL-C and premature atherosclerotic cardiovascular disease (ASCVD). Current guidelines recommend add-on proprotein subtilisin/kexin type 9 inhibitor (PCSK9i) thera
Publikováno v:
Journal of clinical lipidology. 15(5)
HeFH is a common inherited disorder that leads to markedly elevated LDL-cholesterol from birth and premature cardiovascular disease. HeFH is frequently underdiagnosed and undertreated.To compare how well primary care physicians and cardiologists reco
Publikováno v:
Circulation. 142
Background: Liver fibrosis is a complication of non-alcoholic fatty liver disease (NAFLD) and is associated with increased atherosclerotic cardiovascular disease (ASCVD) risk. Whether this risk may be enhanced in persons with pre-diabetes (pre-DM) or
Publikováno v:
Journal of the American College of Cardiology. 77:1539
Publikováno v:
Journal of Clinical Lipidology. 14:586-587
Publikováno v:
Journal of Clinical Lipidology. 14:562-563